Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields

Recent analyst ratings for three high-yielding real estate investment trusts (REITs)—Healthpeak Properties (DOC), Sabra Health Care REIT (SBRA), and Highwoods Properties (HIW)—show mixed sentiment despite their appeal to investors seeking income in turbulent markets, with dividend yields exceeding 6.4%. While some firms reiterated positive ratings and raised price targets, others issued downgrades or cut price targets, indicating divergent institutional perspectives on these income-generating assets. Investors should note upcoming Q2 earnings for DOC and HIW, and Sabra's recent better-than-expected sales.

Analysis

An examination of three high-yield real estate investment trusts reveals divergent analyst sentiment despite their common appeal for income generation in uncertain markets. Sabra Health Care REIT (SBRA), with a 6.49% yield, exhibits the most positive momentum, underscored by a recent report of better-than-expected quarterly sales and supportive analyst actions, including a price target increase to $18 from Truist Securities and a Market Outperform rating from Citizens Capital Market. In contrast, Healthpeak Properties (DOC), offering the highest yield at 6.68%, faces conflicting views; a Wells Fargo price target cut to $20 counters an Argus Research Buy rating with a $25 target, reflecting uncertainty ahead of its Q2 results on July 24. Highwoods Properties (HIW), yielding 6.46%, signals potential weakness with a downgrade from Buy to Hold by Deutsche Bank and a price target reduction by Truist Securities, indicating institutional caution. The upcoming earnings reports for both Healthpeak and Highwoods are therefore critical catalysts that will likely resolve the current ambiguity in their respective outlooks.

Key Decisions for Investors

• Given the conflicting analyst ratings, investors should closely monitor the upcoming Q2 earnings for Healthpeak Properties on July 24 and Highwoods Properties on July 29, as these results will be key to validating either the bullish or bearish theses.
• Sabra Health Care REIT presents a more compelling case among the three, as its recent better-than-expected sales, positive analyst revisions, and strong 0.6 sentiment score suggest fundamental strength supporting its 6.49% dividend yield.
• Investors in Highwoods Properties should exercise caution due to the recent downgrade by Deutsche Bank and a price target cut from Truist, which signal potential headwinds that could impact total return despite the stock's 6.46% yield.
• The significant divergence in analyst opinions for Healthpeak and Highwoods warrants a deeper due diligence into the underlying drivers of each analyst's rating before initiating or adjusting positions.